Karvy
Four New Products Added to Pipeline; Xelpros NDA Submission CompletedSPARC replied to the Complete Response Letter (CRL) from USFDA for Xelpros (Latanoprost BAK-Free) in April 2015, this completes the full submission of NDA for Xelpros.
Sun Pharma Advanced has gained 22.03% in the last 6 Months
More from Sun Pharma Advanced Research Company Ltd.
Recommended